US funding for Lund research for project on adult stem cellsJanuary 29, 2003Adult stem cells are to be treated so that they develop characteristics of nerve cells and can produce dopamine, according to Associate Professor Jia-Yi Li at the Wallenberg Neuro Center at Lund University, who has received a grant of some SEK 2 million from the National Institutes of Health (NIH), the American counterpart of the Swedish Research Council. In recent years only two departments in Sweden have been granted funding from NIH in the field of neurological diseases/stroke, and Jia-Yi Li is the first researcher in Sweden to receive a grant for a stem cell project. The aim of the project is to use adult stem cells as an alternative to embryonic stem cells in transplants for Parkinson's disease. The study focuses on two types of adult stem cells--from bone marrow and from the brain cavity. The project will study the ability of stem cells to form dopamine-producing nerve cells. The projects will be carried out with four phases in which stem cells from bone marrow and the brain are first isolated and purified. In the second phase these stem cells are multiplied in cell cultures. After that they are treated with growth factors, among other things, in order to be able to develop the characteristics of nerve cells. One desirable characteristic is the ability to produce and release the signal substance dopamine. In the last stage of the project these cells will be transplanted in the brains of animal models of Parkinson's disease. "The project will provide us with important knowledge and understanding of adult stem cells. Perhaps we will be able to develop a method for future use in clinical trials with Parkinson's disease," says Jia-Yi Li. Jia-Yi Li has worked since 2001 as an associate professor and post-doctoral fellow at the Section for Nerve Cell Survival at the Wallenberg Neuro Center, Lund University. The project also includes Dr. Gesine Paul, Professors Patrik Brundin and Sten Eirik Jacobsen at Lund University, and Professor Jonas Frisén at the Karolinska Institute in Stockholm. | |||||||||||||||||||||
|
Related Stem Cells News Articles Sugar study is sweetener for stem cell science Scientists at The University of Manchester are striving to discover how the body's natural sugars can be used to create stem cell treatments for heart disease and nerve damage - thanks to a £370,000 funding boost. MIT identifies cells for spinal-cord repair A researcher at MIT's Picower Institute for Learning and Memory has pinpointed stem cells within the spinal cord that, if persuaded to differentiate into more healing cells and fewer scarring cells following an injury, may lead to a new, non-surgical treatment for debilitating spinal-cord injuries. Standards in stem cell research Standards in stem cell research help both scientists and regulators to manage uncertainty and the unknown, according to new research funded by the Economic and Social Research Council. Researchers grow human blood vessels in mice from adult progenitor cells For the first time, researchers have successfully grown functional human blood vessels in mice using cells from adult human donors - an important step in developing clinical strategies to grow tissue, researchers report in Circulation Research: Journal of the American Heart Association. Predicting acute GVHD by gene expression could improve liver stem cell transplant outcomes Many cell transplants involve the use of stem cells from another human being (known as an allograft), which raises the major concern of the potential for acute graft-versus-host disease (GVHD). Stem cell chicken and egg debate moves to unlikely arena: the testes Logic says it has to be the niche. As air and water preceded life, so the niche, that hospitable environment that shelters adult stem cells in many tissues and provides factors necessary to keep them young and vital, must have emerged before its stem cell dependents. Vitamin A pushes breast cancer to form blood vessel cells Researchers at Georgetown University Medical Center have discovered that vitamin A, when applied to breast cancer cells, turns on genes that can push stem cells embedded in a tumor to morph into endothelial cells. These cells can then build blood vessels to link up to the body's blood supply, promoting further tumor growth. UNC study ties ending moderate drinking to depression Scientific evidence has long suggested that moderate drinking offers some protection against heart disease, certain types of stroke and some forms of cancer. Myostatin inhibitors may improve recovery of wartime limb injuries Inhibiting a growth factor that keeps muscles from getting too big may optimize recovery of injured soldiers, researchers say. Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns For the first time in the world scientists have succeeded in developing human embryonic stem cells (hESCs) from a single cell, or blastomere, of a 4-cell stage embryo. More Stem Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||